Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-01 Sale |
2023-06-05 7:31 pm |
Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer |
15,000 | $11.13 | $166,964 | 40,895 (Direct) |
View |
| 2023-05-04 Sale |
2023-05-08 7:35 pm |
Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer |
653 | $10 | $6,530 | 55,895 (Direct) |
View |
| 2023-05-01 Sale |
2023-05-03 8:04 pm |
Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer |
55,177 | $10.06 | $555,267 | 56,548 (Direct) |
View |
| 2023-02-03 Sale |
2023-02-07 5:08 pm |
Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer |
12,998 | $10.02 | $130,236 | 111,725 (Direct) |
View |
| 2023-01-31 Sale |
2023-02-02 6:32 pm |
Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer |
6,172 | $10.01 | $61,810 | 124,723 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-05 5:35 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
3,800 | $23.07 | $87,666 | 86,822 (Direct) |
View |
| 2021-12-01 Sale |
2021-12-03 6:15 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $24.44 | $139,330 | 90,622 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 6:05 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $24.03 | $136,956 | 194,544 (Direct) |
View |
| 2021-10-01 Sale |
2021-10-04 5:51 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $24.83 | $141,506 | 102,022 (Direct) |
View |
| 2021-09-01 Sale |
2021-09-02 6:30 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $26 | $148,223 | 107,722 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-04 7:41 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $28.87 | $164,554 | 113,422 (Direct) |
View |
| 2021-07-13 Sale |
2021-07-15 7:29 pm |
Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer |
43,166 | $32.75 | $1,413,654 | 130,895 (Direct) |
View |
| 2021-07-01 Sale |
2021-07-02 5:41 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $33.33 | $189,987 | 119,122 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-13 Option Award |
2023-06-15 6:24 pm |
N/A 2033-06-12 |
Stoke Therapeutics Inc. | STOK | Krainer Adrian R. Director |
19,441 | $0 | 19,441 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 6:23 pm |
N/A 2033-06-12 |
Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director |
19,441 | $0 | 19,441 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 6:22 pm |
N/A 2033-06-12 |
Stoke Therapeutics Inc. | STOK | Burstein Jennifer Director |
19,441 | $0 | 19,441 (Direct) |
View |
| 2023-03-15 Option Award |
2023-03-17 4:37 pm |
N/A 2033-03-14 |
Stoke Therapeutics Inc. | STOK | Allan Jonathan General Counsel & Corp Sec |
74,700 | $0 | 74,700 (Direct) |
View |
| 2023-03-15 Option Award |
2023-03-17 4:36 pm |
N/A 2033-03-14 |
Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO |
131,000 | $0 | 131,000 (Direct) |
View |
| 2023-03-15 Option Award |
2023-03-17 4:35 pm |
N/A 2033-03-14 |
Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer |
131,000 | $0 | 131,000 (Direct) |
View |
| 2023-03-15 Option Award |
2023-03-17 4:33 pm |
N/A 2033-03-14 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
131,000 | $0 | 131,000 (Direct) |
View |
| 2023-03-15 Option Award |
2023-03-17 4:33 pm |
N/A 2033-03-14 |
Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO |
355,000 | $0 | 355,000 (Direct) |
View |
Ownership |
2023-03-17 3:40 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Allan Jonathan General Counsel & Corp Sec |
0 | $0 | 222,448 (Direct) |
View |
| 2022-12-07 Option Award |
2022-12-09 5:13 pm |
N/A 2032-12-06 |
Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO |
62,000 | $0 | 62,000 (Direct) |
View |
| 2022-12-07 Option Award |
2022-12-09 5:11 pm |
N/A 2032-12-06 |
Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer |
62,000 | $0 | 62,000 (Direct) |
View |
| 2022-12-07 Option Award |
2022-12-09 5:10 pm |
N/A 2032-12-06 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
62,000 | $0 | 62,000 (Direct) |
View |
| 2022-12-07 Option Award |
2022-12-09 5:08 pm |
N/A 2032-12-06 |
Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO |
167,050 | $0 | 167,050 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-08 5:00 pm |
N/A 2032-06-06 |
Stoke Therapeutics Inc. | STOK | LEVIN ARTHUR A Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-08 5:00 pm |
N/A 2032-06-06 |
Stoke Therapeutics Inc. | STOK | Menzel Garry E Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-08 5:00 pm |
N/A 2032-06-06 |
Stoke Therapeutics Inc. | STOK | Burstein Jennifer Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-08 5:00 pm |
N/A 2032-06-06 |
Stoke Therapeutics Inc. | STOK | Krainer Adrian R. Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-08 5:00 pm |
N/A 2032-06-06 |
Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-08 5:00 pm |
N/A 2032-06-06 |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-08 5:00 pm |
N/A 2032-06-06 |
Stoke Therapeutics Inc. | STOK | Smith Julie Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2022-06-02 Exercise |
2022-06-03 5:00 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO |
11,160 | $4.48 | 180,599 (Direct) |
View |
| 2022-06-02 Exercise |
2022-06-03 5:00 pm |
N/A 2029-03-18 |
Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO |
11,160 | $0 | 180,599 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-26 5:16 pm |
N/A 2028-04-02 |
Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO |
15,000 | $0 | 647,801 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-26 5:16 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO |
15,000 | $0.6 | 647,801 (Direct) |
View |
| 2022-03-15 Option Award |
2022-03-17 5:19 pm |
N/A 2032-03-14 |
Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO |
308,000 | $0 | 308,000 (Direct) |
View |
| 2022-03-15 Option Award |
2022-03-17 5:17 pm |
N/A 2032-03-14 |
Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO |
107,400 | $0 | 107,400 (Direct) |
View |
| 2022-03-15 Option Award |
2022-03-17 5:15 pm |
N/A 2032-03-14 |
Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer |
107,400 | $0 | 107,400 (Direct) |
View |
| 2022-03-15 Option Award |
2022-03-17 5:13 pm |
N/A 2032-03-14 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
107,400 | $0 | 107,400 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 5:35 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
3,800 | $2.19 | 86,822 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 5:35 pm |
N/A 2028-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
3,800 | $0 | 86,822 (Direct) |
View |
| 2021-12-01 Exercise |
2021-12-03 6:15 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $2.19 | 90,622 (Direct) |
View |
| 2021-12-01 Exercise |
2021-12-03 6:15 pm |
N/A 2028-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $0 | 90,622 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 6:05 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $2.19 | 194,544 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 6:05 pm |
N/A 2028-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $0 | 194,544 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-04 5:51 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $2.19 | 102,022 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-04 5:51 pm |
N/A 2028-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $0 | 102,022 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-02 6:30 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $2.19 | 107,722 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-02 6:30 pm |
N/A 2028-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $0 | 107,722 (Direct) |
View |
| 2021-08-02 Exercise |
2021-08-04 7:41 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $2.19 | 113,422 (Direct) |
View |
| 2021-08-02 Exercise |
2021-08-04 7:41 pm |
N/A 2028-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $0 | 113,422 (Direct) |
View |
| 2021-07-01 Exercise |
2021-07-02 5:41 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $2.19 | 119,122 (Direct) |
View |
| 2021-07-01 Exercise |
2021-07-02 5:41 pm |
N/A 2028-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $0 | 119,122 (Direct) |
View |
| 2021-06-28 Other |
2021-06-30 4:32 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | ATP Life Science Ventures L.P. ATP III GP Ltd. 10% Owner |
17,161,713 | $0 | 17,161,713 (Direct) |
View |